These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9657473)

  • 41. Novel rectangular biphasic and monophasic waveforms delivered by a radiofrequency-powered defibrillator compared with conventional capacitor-based waveforms in transvenous cardioversion of atrial fibrillation.
    Walsh SJ; Manoharan G; Escalona OJ; Santos J; Evans N; Anderson JM; Stevenson M; Allen JD; Adgey AA
    Europace; 2006 Oct; 8(10):873-80. PubMed ID: 17000635
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transvenous single lead atrial defibrillation: efficacy and risk of ventricular fibrillation in an ischemic canine model.
    Osswald S; Trouton TG; Roelke M; O'Nunain SS; Fallon JT; Holden HB; Ruskin JN; Garan H
    Pacing Clin Electrophysiol; 1998 Mar; 21(3):580-9. PubMed ID: 9558691
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biphasic waveforms prevent the chronic rise of defibrillation thresholds with a transvenous lead system.
    Gold MR; Kavesh NG; Peters RW; Shorofsky SR
    J Am Coll Cardiol; 1997 Jul; 30(1):233-6. PubMed ID: 9207647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Internal atrial defibrillation in humans. Improved efficacy of biphasic waveforms and the importance of phase duration.
    Cooper RA; Johnson EE; Wharton JM
    Circulation; 1997 Mar; 95(6):1487-96. PubMed ID: 9118517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospective comparison of biphasic and monophasic shocks for implantable cardioverter-defibrillators using endocardial leads.
    Saksena S; An H; Mehra R; DeGroot P; Krol RB; Burkhardt E; Mehta D; John T
    Am J Cardiol; 1992 Aug; 70(3):304-10. PubMed ID: 1632393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short biphasic pulses from 90 microfarad capacitors lower defibrillation threshold.
    Swerdlow CD; Kass RM; Davie S; Chen PS; Hwang C
    Pacing Clin Electrophysiol; 1996 Jul; 19(7):1053-60. PubMed ID: 8823832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of transvenous atrial defibrillation of acute and chronic atrial fibrillation and the effect of intravenous sotalol on human atrial defibrillation threshold.
    Lau CP; Lok NS
    Pacing Clin Electrophysiol; 1997 Oct; 20(10 Pt 1):2442-52. PubMed ID: 9358486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relation of atrial refractoriness to upper and lower limits of vulnerability for atrial fibrillation/flutter following implantable ventricular defibrillator shocks.
    Katz A; Sweeney RJ; Gill RM; Reid PR; Prystowsky EN
    Circulation; 1999 Sep; 100(10):1125-30. PubMed ID: 10477539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of phase duration of biphasic waveforms on defibrillation energy requirements with a 70-microF capacitance.
    Schauerte P; Schöndube FA; Grossmann M; Dörge H; Stein F; Dohmen B; Moumen A; Erena K; Messmer BJ; Hanrath P; Stellbrink C
    Circulation; 1998 May; 97(20):2073-8. PubMed ID: 9610539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Internal atrial defibrillation: effect on sinus and atrioventricular nodal function and implanted cardiac pacemakers.
    Prakash A; Saksena S; Mathew P; Krol RB
    Pacing Clin Electrophysiol; 1997 Oct; 20(10 Pt 1):2434-41. PubMed ID: 9358485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transthoracic defibrillation using sequential and simultaneous dual shock pathways: experimental studies.
    Kerber RE; Bourland JD; Kallok MJ; Hite P; Pritchard B; Charbonnier F; Birkett C; Fox-Eastham K; Kieso RA
    Pacing Clin Electrophysiol; 1990 Feb; 13(2):207-17. PubMed ID: 1689837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intra-atrial defibrillation of human atrial fibrillation.
    Santini M; Pandozi C; Gentilucci G; Villani M; Scianaro MC
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S170-6. PubMed ID: 9727694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of atrial defibrillation threshold in internal cardioversion.
    Boriani G; Biffi M; Camanini C; Bacchi L; Zannoli R; Luceri R; Branzi A
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1898-901. PubMed ID: 11139953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-energy transvenous cardioversion of atrial fibrillation using a single atrial lead system.
    Heisel A; Jung J; Neuzner J; Michel U; Pitschner H
    J Cardiovasc Electrophysiol; 1997 Jun; 8(6):607-14. PubMed ID: 9209961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transthoracic defibrillation: effect of dual-pathway sequential pulse shocks and single-pathway biphasic pulse shocks in a canine model.
    Scott BD; Kallok MJ; Birkett C; Kieso RA; Kerber RE
    Am Heart J; 1993 Jan; 125(1):99-109. PubMed ID: 8417549
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ventricular defibrillation with triphasic waveforms.
    Huang J; KenKnight BH; Rollins DL; Smith WM; Ideker RE
    Circulation; 2000 Mar; 101(11):1324-8. PubMed ID: 10725294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Waveform optimization for internal atrial defibrillation: effects of waveform rounding, phase duration, and voltage swing.
    Kidwai BJ; Allen JD; Harbinson MT; McIntyre A; Anderson J; Adgey AA
    Pacing Clin Electrophysiol; 2001 Aug; 24(8 Pt 1):1198-207. PubMed ID: 11523604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Defibrillation electrode configurations developed from cardiac mapping that combine biphasic shocks with sequential timing.
    Guse PA; Walcott GP; Rollins DL; Smith WM; Ideker RE
    Am Heart J; 1992 Dec; 124(6):1491-500. PubMed ID: 1462904
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low-energy transvenous cardioversion defibrillation of atrial tachyarrhythmias in the canine: an assessment of electrode configurations and monophasic pulse sequencing.
    Benditt DG; Dunbar D; Fetter J; Sakaguchi S; Lurie KG; Adler SW
    Am Heart J; 1994 Apr; 127(4 Pt 2):994-1003. PubMed ID: 8160604
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans.
    Murgatroyd FD; Slade AK; Sopher SM; Rowland E; Ward DE; Camm AJ
    J Am Coll Cardiol; 1995 May; 25(6):1347-53. PubMed ID: 7722132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.